ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2023

Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Sneha Annie Sebastian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.